Back to Report Store Home

Myeloma Therapeutics in Asia-Pacific Markets to 2021 – Growth Driven by Rising Prevalence, Continued Success of Velcade, Revlimid and Emerging Supplementary Treatments

  • Published: Oct-2015
  • Report Code: GBIHC370MR
  • Report Format: pdf

Description

List of Tables

Table 1: Multiple Myeloma Therapeutics Market, Initial Screening in Suspected Myeloma Patients 13

Table 2: Multiple Myeloma Therapeutics Market, Diagnostic Criteria for MGUS, Asymptomatic Myeloma and Symptomatic Myeloma 14

Table 3: Multiple Myeloma Therapeutics Market, Myeloma-Related Organ or Tissue Impairment 14

Table 4: Multiple Myeloma Therapeutics Market, Disease Staging, Durie-Salmon Staging System 16

Table 5: Multiple Myeloma Therapeutics Market, Prognostic Factors 18

Table 6: Multiple Myeloma Therapeutics Market, Prognostic Factors 19

Table 7: Multiple Myeloma Therapeutics Market, Global, Pipeline Products, Discovery, 2015 95

Table 8: Multiple Myeloma Therapeutics Market, Global, Pipeline Products, Preclinical, 2015 97

Table 9: Multiple Myeloma Therapeutics Market, Global, Pipeline Products, IND/CTA-filed, 2015 100

Table 10: Multiple Myeloma Therapeutics Market, Global, Pipeline Products, Phase I, 2015 101

Table 11: Multiple Myeloma Therapeutics Market, Global, Pipeline Products, Phase II, 2015 104

Table 12: Multiple Myeloma Therapeutics Market, Global, Pipeline Products, Phase III, 2015 107

Table 13: Multiple Myeloma Therapeutics Market, Global, Pipeline Products, Pre-registration, 2015 107

Table 14: Multiple Myeloma Therapeutics Market, Asia-Pacific, Market Forecast, 2014–2021 108

Table 15: Multiple Myeloma Therapeutics Market, India, Market Forecast, 2014–2021 108

Table 16: Multiple Myeloma Therapeutics Market, China, Market Forecast, 2014–2021 109

Table 17: Multiple Myeloma Therapeutics Market, Australia, Market Forecast, 2014–2021 109

Table 18: Multiple Myeloma Therapeutics Market, Japan, Market Forecast, 2014–2021 110

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$4995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$9990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$14985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards